+91-9836913164 (India),  +1-917-730-4660 (U.S.)
Blue Biotechnology Market is expected to grow at CAGR 11.3% between 2018-2025 - Global Industry Size, Share, Growth, Market Analysis and Forecast
Published : August 2018

Global Blue Biotechnology market in terms of revenue is expected to grow at 11.3% CAGR between 2018 to 2025 as per new market research report titled Global Blue Biotechnology Market (by product type- pharma, biofuels, food, enzymes, biopolymers, and others. By application-vaccine development, drug finding, genomics, and others. By end-user-pharmaceutical companies, biotechnology companies, research organizationhealth care center, and others) – Global industry analysis, size, share, growth, trends, and forecast, 2018 – 2025, by Sheer Analytics & Insights Pvt. Ltd.





Global Blue Biotechnology Market CAGR Forecast 2018 - 2025 Sheer Analytics and Insights



The market of the blue biotechnology is booming rapidly, and are mainly used in the healthcare, pharmaceutical sector. Blue biotechnology products are also used for the various treatment such as antiviral, bones, wounds, and uncontaminated among others and thus Global blue biotechnology market is estimated to rise in the coming years.



In addition to this, the market for blue biotechnology is also creating huge opportunities in the field of sea monitoring. Research and development by the key players for manufacturing new products which include enzymes, drug finding is also influencing the market growth of blue biotechnology across the globe. Currently, the increasing development of new aquatic technology which was used for monitoring the sea atmosphere coupled with the surge of algae-derived bioenergy development, and increasing demand for marine renewable energy are some of the major factors which are highly inducing the growth of Global blue biotechnology.



There has been considerable growth in terms of research in the Blue-Biotechnology segment. Recently, a team of biologists and researchers from the NYU Abu Dhabi collaborated with the UAE University to conduct some researches that allowed them to grow food-producing and critical oxygen-producing algae under conditions that were considered to be inhabitable for these microorganisms. As per the lead researcher, Weiqi Fu, Ph.D., Research Scientist, NYU Abu Dhabi, “With this technology, algae can be grown in photo-bioreactors at a higher density and a faster pace, reducing cost and speeding up production.”



Additionally, the increasing number of blue biotechnology products in the North-America makes the region to hold the largest market share of blue biotechnology. Moving forward, increasing focus on marine technology for the research and development of new drug has augmented the growth of this market in the countries like U.S, France, Italy, and in Germany. The constant growth of marine-based organisms such as bacteria, algae among others in Brazil, Chile, makes the demand for the blue biotechnology products in the Middle East and Africa region. The second largest market of blue biotechnology in Europe because of high demand for the marine products in this region. Due to less application of this market in several areas of India, China makes the stable growth of blue biotechnology in Asia Pacific market.



Sheer Analytics & Insights recently published a market research report on Global blue biotechnology market and the market has been segmented based on the product type, application, and end-user. Based on product type, Global blue biotechnology market is divided into pharma, biofuels, food, enzymes, biopolymers, and others. Based on its application, Global blue biotechnology market is segmented into vaccine development, drug finding, genomics, and others. There are several end-users of this market which make use of the blue biotechnology which includes pharmaceutical companies, biotechnology companies, research organization, health care center, and others. Moving forward, the market is geographically segmented into North America, Middle East & Africa, Asia-Pacific, and Latin America.



Marinova launched marine ingredient product Maritech fucoidan and the key feature of this product is to help in boosting the immune cells and for reducing the allergic responses. Moreover, the latest study shows that this product has the ability to kill the cancer cells directly and thus it is expected to drive the blue biotechnology market in the foreseeable period.



The major companies in GlobalBlue Biotechnology market are as follows, Aker Biomarine, GeoMarine Biotechnologies, GlycoMar, New England Biolabs, Pml Application Ltd., Sea Run Holdings, Inc., Shell Marine Products, and Samudra Biopharma Private Limited among others.


Global Blue Biotechnology Market: By Product Type

  • Pharma
  • Biofuels
  • Food
  • Enzymes
  • Biopolymers
  • Others


Global Blue Biotechnology Market: By Application

  • Vaccine development
  • Drug finding
  • Genomics
  • Others


Global Blue BiotechnologyMarket: By End- User

  • Pharmaceutical companies
  • Biotechnology companies
  • Research organization
  • Healthcare Centre
  • Others


Global Blue Biotechnology Market: By Geography

North America

  • U.S.
  • Canada
  • Mexico


  • U.K.
  • France
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • India
  • China
  • Japan
  • Rest of Asia Pacific

Middle East and Africa

  • South Africa
  • Rest of the Middle East and Africa

Latin America

  • Brazil
  • Rest of Latin America



About Sheer Analytics and Insights Private Limited

Sheer Analytics and Insights Pvt. Ltd. is among the leading market research organizations providing the best B2B researches on various niches. Currently servicing 2000+ clients worldwide, our analysts and marketing team are continually tracking global markets having high growth prospect.

Contact info

Contact Number: +913346009199

Email Address: sales@sheeranalyticsandinsights.com

Copyright © 2018 Sheer Analytics and Insights

All Rights Reserved. This document contains highly confidential information and is the sole property of the Company. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of the company.